Algeta results for the first half and second quarter 2012
Oslo, Norway, 16 August 2012 - Algeta ASA, a company focused on the development of novel targeted cancer therapeutics, announces its results for the first half and second quarter 2012.
Yesterday I let you know that RIM would be reporting their second quarter fiscal 2012 results today.